Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-21 | Mr. Davis holds a B.S. from the U.S. Naval Academy and an M.B.A. from Harvard University. |
| 2015-03-13 | Mr. Davis holds a B.S. from the U.S. Naval Academy and an M.B.A. from Harvard University. He has experience in pharmaceutical and biotechnology industries but no programming or technical degrees. |
| 2016-04-12 | He is a Founding Managing Director of HealthCare Royalty Partners, a global healthcare investment firm. He has over 32 years of experience working in and investing in the pharmaceutical and biotechnology industries. |
| 2017-04-14 | Mr. Davis holds a B.S. from the U.S. Naval Academy and an M.B.A. from Harvard University. |
| 2018-04-30 | Mr. Davis holds a B.S. from the U.S. Naval Academy and an M.B.A. from Harvard University. He has over three decades of experience working in and investing in the pharmaceutical and biotechnology industries. |
| 2019-04-24 | Mr. Davis is a navy veteran and holds a B.S. from the U.S. Naval Academy and an M.B.A. from Harvard University. |
| 2020-04-24 | Mr. Davis has almost thirty years of experience in both operations and investing in the biopharmaceutical and life science industries. |
| 2020-11-12 | Todd C. Davis is a non-employee director; no software-related skills or technical background mentioned. |
| 2021-04-23 | Mr. Davis is Founder and Managing Partner of RoyaltyRx Capital, with experience in healthcare financings and investments. |
| 2022-04-22 | Mr. Davis is Founder and Managing Partner of RoyaltyRx Capital, with experience in healthcare financings and intellectual property licenses. |
| 2023-04-20 | Mr. Davis was the Founder and Managing Partner of RoyaltyRx Capital, a special opportunities investment firm founded in 2018. He has almost thirty years of experience in both operations and investing in the biopharmaceutical and life sciences industries. He holds a B.S. from the U.S. Naval Academy and an M.B.A. from Harvard University. |
| 2024-04-25 | Mr. Davis was the Founder and Managing Partner of RoyaltyRx Capital, a special opportunities investment firm founded in 2018. From 2006 until 2018, Mr. Davis was a Founder and Managing Partner of HealthCare Royalty Partners, a global healthcare investment firm. |
| Filing Date | Source Excerpt |
|---|---|
| 2001-04-06 | Since February 1999 Mr. Davis has served as Director, Strategic Planning of Elan Corporation, plc, an Irish pharmaceutical company. |
| 2002-04-30 | Mr. Davis was the Vice President of Global Licensing and Business Development for Elan Drug Delivery Company, an affiliate of Elan Corporation, plc, an Irish pharmaceutical company. From February 1999 until April 2000, Mr. Davis served as Director, Strategic Planning of Elan Corporation, plc. |
Data sourced from SEC filings. Last updated: 2025-10-11